WUHAN, April 9 (Xinhua) -- A Chinese biopharmaceutical company has realized large-scale production of rice-derived albumin, ...

A Wuhan-based biopharmaceutical company developed technology to synthesize human serum albumin (HSA) from rice, offering a ...

Hepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive ...

Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonnet discuss the recently announced safety data ...

Medical scientists said the breakthrough will help alleviate China's shortage of human serum albumin (HSA). HSA is a blood product vital in the treatment of a number of medical conditions ...